Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;123(9):21-25.
doi: 10.17116/jnevro202312309121.

[The development of multiple sclerosis over the age of 50]

[Article in Russian]
N Yu Lashch  1 , A E Pavlikov  1 , A N Boyko  1   2
Affiliations

[The development of multiple sclerosis over the age of 50]

[Article in Russian]
N Yu Lashch et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2023.

Abstract
in English, Russian

Multiple sclerosis (MS) is a common neurological disease among young people of working age, which tends to increase the number of cases registered in the world and in the Russian Federation. However, with improved diagnostics and the emergence of new drugs that change the course of MS (disease-modifying therapy), people's life expectancy increases and the percentage of patients in the older age group increases as well. In this article, we consider the possibility of developing MS among people over 50 years of age, features of the course, diagnosis and treatment.

Рассеянный склероз (РС) — распространенное неврологическое заболевание среди лиц молодого трудоспособного возраста, имеющее тенденцию к увеличению числа случаев, зарегистрированных в мире и в Российской Федерации. Однако с улучшением диагностики и появлением новых препаратов, изменяющих течение РС (ПИТРС), увеличивается продолжительность жизни людей и увеличивается процент пациентов в старшей возрастной группе.

Keywords: age; beta-interferon1a; cladribine; dimethylfumarate; disease-modifying treatments (DMT); elderly patients; multiple sclerosis; natalizumab; teriflunomide; young patients.

PubMed Disclaimer

Publication types

LinkOut - more resources